Boyiadzis, Michael M.
Kirkwood, John M.
Marshall, John L.
Pritchard, Colin C.
Azad, Nilofer S.
Gulley, James L.
Article History
Received: 10 January 2018
Accepted: 19 April 2018
First Online: 14 May 2018
Ethics approval and consent to participate
: Not applicable
: JMK declared that he received personal fees from Bristol-Myers Squibb Co., Merck & Co., Novartis International AG., F. Hoffmann-La Roche, Ltd., Genentech, Inc., Merck EMD, and Array BioPharma, Inc. JLM declared that he received personal fees from Merck & Co. All remaining authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.